首页|期刊导航|Oncology Research|Investigation on the Anti-Cancer Effects of HER2-Targeted CAR-T Cells Engineered Using the PiggyBac Transposon System
Investigation on the Anti-Cancer Effects of HER2-Targeted CAR-T Cells Engineered Using the PiggyBac Transposon System
Tian-Tian Li Ming-Yao Meng Zheng Yu Yang-Fan Guo Yi-Yi Zhao Hui Gao Li-Li Yang Li-Rong Yang Meng-Yuan Chu Shan He Yuan Liu Xiao-Dan Wang Wen-Ju Wang Zong-Liu Hou Li-Wei Liao Lin Li
Oncology Research2025,Vol.33Issue(11):P.3447-3467,21.
Oncology Research2025,Vol.33Issue(11):P.3447-3467,21.DOI:10.32604/or.2025.065394
Investigation on the Anti-Cancer Effects of HER2-Targeted CAR-T Cells Engineered Using the PiggyBac Transposon System
摘要
关键词
Chimeric antigen receptor T/human endothelial growth factor receptor 2/cell therapy/PiggyBac transposase分类
医药卫生引用本文复制引用
Tian-Tian Li,Ming-Yao Meng,Zheng Yu,Yang-Fan Guo,Yi-Yi Zhao,Hui Gao,Li-Li Yang,Li-Rong Yang,Meng-Yuan Chu,Shan He,Yuan Liu,Xiao-Dan Wang,Wen-Ju Wang,Zong-Liu Hou,Li-Wei Liao,Lin Li..Investigation on the Anti-Cancer Effects of HER2-Targeted CAR-T Cells Engineered Using the PiggyBac Transposon System[J].Oncology Research,2025,33(11):P.3447-3467,21.基金项目
supported by the Yunnan Fundamental Research Projects,China(Grant No.202201AS070068) (Grant No.202201AS070068)
Central Funds Guiding the Local Science and Technology Development,China(202207AB110017) (202207AB110017)
The Science and Technology Fund of Kunming City,China(No.2019-1-N-25318000002027) (No.2019-1-N-25318000002027)
The Scientific and Technological Innovation Team in Kunming Medical University,China(CXTD202215). (CXTD202215)